Woodley Farra Manion Portfolio Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.4M Sell
31,948
-187
-0.6% -$190K 1.43% 29
2025
Q4
$34.5M Buy
32,135
+337
+1% +$322K 1.65% 26
2025
Q3
$24.3M Sell
31,798
-557
-2% -$414K 1.14% 30
2025
Q2
$25.2M Sell
32,355
-570
-2% -$443K 1.19% 30
2025
Q1
$27.2M Sell
32,925
-882
-3% -$734K 1.35% 29
2024
Q4
$26.1M Buy
33,807
+270
+0.8% +$224K 1.3% 29
2024
Q3
$29.7M Sell
33,537
-509
-1% -$458K 1.5% 29
2024
Q2
$30.8M Sell
34,046
-160
-0.5% -$128K 1.67% 27
2024
Q1
$26.6M Sell
34,206
-2,200
-6% -$1.57M 1.46% 30
2023
Q4
$21.2M Buy
36,406
+286
+0.8% +$167K 1.27% 30
2023
Q3
$19.4M Sell
36,120
-28,722
-44% -$14.8M 1.29% 29
2023
Q2
$30.4M Buy
64,842
+997
+2% +$418K 1.96% 25
2023
Q1
$21.9M Buy
63,845
+270
+0.4% +$91.1K 1.49% 29
2022
Q4
$23.3M Sell
63,575
-68
-0.1% -$24.1K 1.69% 27
2022
Q3
$20.6M Buy
63,643
+1,452
+2% +$460K 1.67% 26
2022
Q2
$20.2M Sell
62,191
-474
-0.8% -$142K 1.65% 26
2022
Q1
$17.9M Buy
62,665
+280
+0.4% +$72.1K 1.34% 26
2021
Q4
$17.2M Buy
62,385
+259
+0.4% +$65.7K 1.2% 28
2021
Q3
$14.4M Sell
62,126
-308
-0.5% -$76K 1.19% 29
2021
Q2
$14.3M Buy
62,434
+813
+1% +$163K 1.11% 29
2021
Q1
$11.5M Buy
61,621
+849
+1% +$166K 0.96% 28
2020
Q4
$10.3M Buy
60,772
+30,371
+100% +$4.53M 0.91% 27
2020
Q3
$4.5M Buy
30,401
+860
+3% +$133K 0.47% 31
2020
Q2
$4.85M Buy
29,541
+2
+0% +$307 0.51% 30
2020
Q1
$4.1M Buy
29,539
+275
+0.9% +$37.8K 0.49% 31
2019
Q4
$3.85M Buy
29,264
+9,615
+49% +$1.11M 0.36% 44
2019
Q3
$2.2M Sell
19,649
-1,290
-6% -$144K 0.22% 48
2019
Q2
$2.32M Buy
20,939
+217
+1% +$25.6K 0.23% 48
2019
Q1
$2.69M Sell
20,722
-205
-1% -$24.9K 0.29% 45
2018
Q4
$2.42M Sell
20,927
-414
-2% -$46.2K 0.29% 47
2018
Q3
$2.29M Buy
21,341
+1,637
+8% +$164K 0.24% 48
2018
Q2
$1.68M Sell
19,704
-89
-0.4% -$7.31K 0.19% 48
2018
Q1
$1.53M Hold
19,793
0.17% 50
2017
Q4
$1.67M Sell
19,793
-648
-3% -$55.1K 0.18% 51
2017
Q3
$1.75M Buy
20,441
+1,014
+5% +$83.2K 0.2% 50
2017
Q2
$1.6M Hold
19,427
0.21% 51
2017
Q1
$1.63M Hold
19,427
0.21% 53
2016
Q4
$1.43M Buy
19,427
+1
+0% +$74 0.19% 55
2016
Q3
$1.56M Sell
19,426
-95
-0.5% -$7.6K 0.23% 51
2016
Q2
$1.54M Buy
19,521
+324
+2% +$24.4K 0.24% 50
2016
Q1
$1.38M Sell
19,197
-2,393
-11% -$181K 0.23% 52
2015
Q4
$1.82M Buy
21,590
+8,980
+71% +$745K 0.32% 49
2015
Q3
$1.05M Sell
12,610
-120
-0.9% -$10.1K 0.21% 50
2015
Q2
$1.06M Buy
12,730
+4,259
+50% +$325K 0.2% 51
2015
Q1
$615K Buy
8,471
+637
+8% +$45.4K 0.11% 57
2014
Q4
$540K Sell
7,834
-60
-0.8% -$4.05K 0.1% 56
2014
Q3
$512K Hold
7,894
0.1% 59
2014
Q2
$491K Sell
7,894
-830
-10% -$49.5K 0.09% 61
2014
Q1
$513K Sell
8,724
-3,179
-27% -$177K 0.1% 56
2013
Q4
$607K Sell
11,903
-324
-3% -$16.2K 0.11% 55
2013
Q3
$615K Buy
12,227
+1,857
+18% +$97.2K 0.13% 53
2013
Q2
$509K Buy
+10,370
New +$564K 0.11% 56

Other funds holding LLY

Woodley Farra Manion Portfolio Management's LLY Position: Q1 2026 in Review

Woodley Farra Manion Portfolio Management reduced its Eli Lilly (LLY) stake by 0.58% in Q1 2026, selling an estimated $190K and leaving 31,948 shares worth $29.4M. The position accounts for 1.43% of the portfolio, ranked #29.

Woodley Farra Manion Portfolio Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $34.5M in Q4 2025. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Woodley Farra Manion Portfolio Management held 31,948 shares of Eli Lilly worth $29.4M as of Q1 2026.
  • Woodley Farra Manion Portfolio Management sold 187 Eli Lilly shares in Q1 2026, an estimated $190K.
  • Eli Lilly made up 1.43% of Woodley Farra Manion Portfolio Management's portfolio in Q1 2026, its #29 holding.
  • Woodley Farra Manion Portfolio Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Woodley Farra Manion Portfolio Management's Eli Lilly position peaked at $34.5M in Q4 2025.
  • 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Woodley Farra Manion Portfolio Management's 13F filing for Q1 2026, filed 8 May 2026.